Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
about
Gadolinium contrast media during pregnancy and lactation25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesBreast MRI: EUSOBI recommendations for women's informationDynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients.Retroperitoneal fibrosis - the state-of-the-artRadiological staging in pregnant patients with cancerTreatment of gynecological cancers diagnosed during pregnancy.Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisImpact of contrast-enhanced ultrasound in patients with renal function impairmentReliability of magnetic resonance elastography using multislice two-dimensional spin-echo echo-planar imaging (SE-EPI) and three-dimensional inversion reconstruction for assessing renal stiffness.Imaging for acute pelvic pain in pregnancy.Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging.Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Brain imaging of neurovascular dysfunction in Alzheimer's disease.Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological SocietyComparison of diffusion-weighted imaging and contrast-enhanced T1-weighted imaging on a single baseline MRI for demonstrating dissemination in time in multiple sclerosis.StatSensor-i point-of-care creatinine analyzer may identify patients at high-risk of contrast-induced nephropathy.Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practiceSafety and efficacy of gadobutrol-enhanced MRI in patients aged under 2 years-a single-center, observational study.Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipomaDelayed gadolinium-enhanced MRI of the fibrocartilage disc of the temporomandibular joint--a feasibility study.Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis.[Elective organ and function preservation in ureter and renal pelvis tumors].Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment: results of a prospective, open-label, multicenter studyRevisiting the risks of MRI with Gadolinium based contrast agents-review of literature and guidelines.Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Gadolinium retention in the body: what we know and what we can do.Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional studySafety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million ApplicationsSafety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.Gadobutrol in Renally Impaired Patients: Results of the GRIP Study.The role of imaging in the active surveillance of small renal masses.Intracranial lesions with high signal intensity on T1-weighted MR images - review of pathologies.Contrast-enhanced CT and MR imaging of renal vessels.When dementia progresses quickly: a practical approach to the diagnosis and management of rapidly progressive dementia.Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.Surveillance after endovascular abdominal aortic aneurysm repair.The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.
P2860
Q22065340-B843EEE2-1FE1-4C57-9E4D-B83CA6794059Q26774810-30F37239-51B5-4CAA-884A-3D770B300DB4Q27323080-55F73702-B06A-4B14-8E00-46C615F23C53Q27342287-1D075DB1-4872-4FBE-9B34-308C32EB86D4Q28078367-1EB7DD38-1099-421E-9978-00E5B33AD354Q28079904-7AF7260A-9F16-4BC8-AF0E-4E23102A49BEQ30249061-67E8C075-0EF7-43D0-BD07-A12B95AE2BBBQ30278095-F2A38B15-6D08-4F61-97DC-EDD64B1F6FD1Q30364826-3CFFB6F4-B123-48E2-994D-D3EB28581589Q30375325-82BC9563-7F43-4F69-9ACC-D9A7B23F9849Q30439632-BF54BE8A-2993-40A0-8936-1DAAE13916FDQ30708177-9E57ECB3-223C-4A2E-AFFE-ADC80A09D7BCQ30818733-14AB0F24-DC6F-43F1-B92A-409325C10E34Q31066988-231ADCBB-4C8D-4958-9B3B-DE87DEBE3EECQ31123447-6C8DBB43-1A38-4357-9A79-D50C6A91F08AQ33677013-71FD0E4F-3A20-489B-AEA5-99B0BCCEFCADQ33744054-990C7107-56F4-4789-AFCF-C95E632F8BD0Q33873443-6153365F-B46F-4F88-9107-577EF1457425Q33873742-7190006A-9C01-4A50-8121-809A34552762Q34404435-18AEDC93-9A26-40C2-8656-ED3D496128C0Q34491147-D519D374-7CCA-4712-8097-7756420CC123Q35044664-C4ECAA4A-D784-4724-B252-F0F52D3008DFQ35230042-346FAD2A-7D7F-4209-8921-E5E228B61CFEQ35570797-6DC9205B-3636-41D2-8ED2-0CE52D0B53E0Q36059081-1B13CD52-D3CF-461A-A102-C9EC8680033EQ36295407-EB875CF7-8A7C-48C6-A82C-964C8F7DB690Q36316226-0533EDC0-5ED9-4809-8E0B-A5B0E300302DQ36329191-E4C686C7-ECF7-4E5B-AD67-F15B28436554Q37092639-FC38D712-31F3-4311-9410-CE30FB40B952Q37170996-CC762973-01A4-4F3A-B6B0-FD26D7F9C9BEQ37452679-77A948D6-A2EB-4F35-ACB7-3EE3518EA669Q37486093-FE2213FE-98D7-4E64-B2BB-C8201F02A7E0Q38178123-B37035CD-9D98-4454-B7DB-1052DFBE2304Q38186020-A924A63F-000F-4FB9-B542-18F095163F4AQ38194953-271EC0B5-2728-4415-BA5F-E63EFFF9F8DFQ38196861-202C74E5-3BF9-4E56-B8DF-2153EAEE7817Q38207541-E6BA17D2-1A6D-46AA-9143-A3AF29167D30Q38215797-DA3135C6-828B-4036-98C7-A098B0875FE5Q38246679-B1593923-352E-475F-8922-1B3F2785D609Q38254508-DC275322-5639-4FF2-9F71-374BD762AC88
P2860
Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nephrogenic systemic fibrosis ...... m Safety Committee guidelines.
@en
type
label
Nephrogenic systemic fibrosis ...... m Safety Committee guidelines.
@en
prefLabel
Nephrogenic systemic fibrosis ...... m Safety Committee guidelines.
@en
P2093
P2860
P1433
P1476
Nephrogenic systemic fibrosis ...... m Safety Committee guidelines.
@en
P2093
Aart van der Molen
ESUR Contrast Medium Safety Committee
Fulvio Stacul
Georg Bongartz
Gertraud Heinz-Peer
Henrik S Thomsen
Judith A W Webb
Marie-France Bellin
Michele Bertolotto
Olivier Clement
P2860
P2888
P304
P356
10.1007/S00330-012-2597-9
P407
P577
2012-08-04T00:00:00Z